✦ LIBER ✦

An (only) partially established paradigm of drug development of targeted therapies

✍ Scribed by Rodon, Jordi

Book ID: 124116070
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 284 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.04.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Developing a paradigm of drug innovation

Developing a paradigm of drug innovation: an evaluation algorithm

✍ Luciano Caprino; Pierluigi Russo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 840 KB

Targeting HIV: antiretroviral therapy an

Targeting HIV: antiretroviral therapy and development of drug resistance

✍ Luis Menéndez-Arias 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Anticancer drug development from traditi

Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan

✍ E. Kawabata-Shoda; S. Masuda; H. Kimura 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Targeted gene therapy: frontiers in the

Targeted gene therapy: frontiers in the development of ‘smart drugs’

✍ Ingo H. Tarner; Ulf Müller–Ladner; C.Garrison Fathman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Effects on metastases of drug therapy du

Effects on metastases of drug therapy during developing and established tumor immunity

✍ Jan Vaage; Mary E. Costanza 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 486 KB

## Abstract The effectiveness of treatment with cyclophosphamide, methotrexate and 5‐fluorouracil was studied during the s.c. and pulmonary growth of syngeneic C3H/He mammary carcinomas. Treatments with cyclophosphamide, methotrexate and 5‐fluorouracil __during__ the primary induction of immunity a

Strategy Escalation: An emerging paradig

Strategy Escalation: An emerging paradigm for safe clinical development of T cell gene therapies

✍ Richard Paul Junghans 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 506 KB